Scopa James Paul

CIK 0001356950

Director

Filings

Latest Dec 10, 2025

Issuers covered

Showing

19 of 19

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Scopa James Paul. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Scopa James Paul has filed

Ticker	Issuer	Filings	Last filed
DICE	Dice Therapeutics, Inc.	7	Aug 9, 2023
ADVM	Adverum Biotechnologies, Inc.	6	Dec 10, 2025
ALGS	Aligos Therapeutics, Inc.	6	Jun 26, 2025

19 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Dec 10, 2025	ADVMAdverum Biotechnologies, Inc.	UTender	10,333	-	-
Jun 26, 2025	ALGSAligos Therapeutics, Inc.	Holdings only	-	-	-
Jun 20, 2025	ADVMAdverum Biotechnologies, Inc.	Holdings only	-	-	-
Jun 28, 2024	ALGSAligos Therapeutics, Inc.	Holdings only	-	-	-
Jun 20, 2024	ADVMAdverum Biotechnologies, Inc.	Holdings only	-	-	-
Feb 28, 2024	ALGSAligos Therapeutics, Inc.	Holdings only	-	-	-
Feb 9, 2024	ADVMAdverum Biotechnologies, Inc.	PPurchase	100,000	$1.35	$135,000
Oct 27, 2023	ALGSAligos Therapeutics, Inc.	AGrant	183,083	$0.7568	$138,557
Aug 9, 2023	DICEDice Therapeutics, Inc.	DDisposition	15,199	-	-
Aug 3, 2023	DICEDice Therapeutics, Inc.	GGift	220	$0.00	$0
Jul 21, 2023	ALGSAligos Therapeutics, Inc.	Holdings only	-	-	-
Jul 19, 2023	DICEDice Therapeutics, Inc.	GGift	2,200	$0.00	$0
Jul 13, 2023	DICEDice Therapeutics, Inc.	GGift	300	$0.00	$0
Jun 13, 2023	ADVMAdverum Biotechnologies, Inc.	Holdings only	-	-	-
May 2, 2023	DICEDice Therapeutics, Inc.	GGift	6,923	$0.00	$0
Mar 21, 2023	DICEDice Therapeutics, Inc.	SSale	10,000	$29.05	$290,500
Jun 27, 2022	ALGSAligos Therapeutics, Inc.	Holdings only	-	-	-
Jun 14, 2022	ADVMAdverum Biotechnologies, Inc.	Holdings only	-	-	-
Jun 8, 2022	DICEDice Therapeutics, Inc.	Holdings only	-	-	-

Showing 1-19 of 19

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.